Preliminary clinical experience with E-39, a new drug for advanced cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use